Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic models in melanoma

A C Halpern1, L M Schuchter

  • 1Department of Dermatology, University of Pennsylvania, Philadelphia 19104, USA.

Seminars in Oncology
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to 'Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma': [Annals of Oncology 34 (2023) 806-812].

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

3D Whole-body skin imaging for automated melanoma detection.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

The long-term evolution of melanocytic nevi among high-risk adults.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Skin cancer risk among testicular germ-cell cancer survivors: a systematic review and meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Accuracy of commercially available smartphone applications for the detection of melanoma.

The British journal of dermatology·2021

Accurately predicting melanoma metastasis is crucial for treatment. New models using tumor characteristics and clinical factors improve survival prediction for primary melanoma patients.

Area of Science:

  • Oncology
  • Dermatology
  • Biostatistics

Background:

  • Accurate prediction of metastatic melanoma is vital for guiding therapeutic decisions.
  • While tumor thickness is a common prognostic factor, other clinical and pathological variables are also important.
  • Developing robust predictive models for primary melanoma survival remains a clinical challenge.

Purpose of the Study:

  • To develop and validate multivariate logistic regression models for predicting survival in primary melanoma patients.
  • To identify key independent predictors of survival in different melanoma growth phases.
  • To provide clinical algorithms for risk assessment in melanoma management.

Main Methods:

  • Development of two multivariate logistic regression models to predict survival.

Related Experiment Videos

  • Classification of patients into groups based on radial or vertical growth phase.
  • Inclusion of variables such as mitotic rate, tumor-infiltrating lymphocytes, tumor thickness, anatomic site, sex, and histologic regression in the models.

    • Main Results:

    • The first model, incorporating six variables for vertical growth phase tumors, achieved 89% accuracy in predicting survival.
    • A second model utilizing readily available clinical parameters (tumor thickness, anatomic site, age, sex) was developed.
    • These four clinical variables were identified as powerful independent predictors of survival.

    Conclusions:

    • Multivariate models effectively predict survival in primary melanoma patients.
    • Specific clinical and pathological variables significantly enhance prognostic accuracy.
    • The developed models and algorithms can aid in rational therapeutic decision-making for melanoma.